Research Topics
| Michael AnderssonSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin diseaseLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
JAMA 290:465-75. 2003..Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk...- Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphomaLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
J Natl Cancer Inst 97:1428-37. 2005..We estimated this future risk, taking into account age and calendar year of HL diagnosis, HL treatment information, population breast cancer incidence rates, and competing causes of death... - Leukemia following breast cancer: an international population-based study of 376,825 womenRegan A Howard
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7091, Bethesda, MD 20892, USA
Breast Cancer Res Treat 105:359-68. 2007.... - Merkel cell carcinoma and multiple primary cancersRegan A Howard
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
Cancer Epidemiol Biomarkers Prev 15:1545-9. 2006..Heightened awareness of the associations of lymphohematopoietic malignancies with MCC may facilitate early clinical recognition... 
Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patientsRegan Howard
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Ann Epidemiol 18:416-21. 2008..The aim of this study is to quantify excess absolute risk (EAR) and excess relative risk (ERR) of secondary leukemia among a large population-based group of testicular cancer survivors...
Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health StudyRegan A Howard
Division of Cancer Epidemiology and Genetics, Radiation Epidemiology Branch, National Cancer Institute, NIH, DHHS, Bethesda, MD, 20892, USA
Cancer Causes Control 19:939-53. 2008..In order to prospectively investigate physical activity at varying intensities and sedentary behavior in relation to colorectal cancer...- Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patientsSara J Schonfeld
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-7238, USA
J Natl Cancer Inst 98:215-8. 2006..The EAR of AML declined statistically significantly after 1984 (7.0 to 4.2 and 16.4 to 9.9 in the < 35 and > or = 35 age groups, respectively), which may be associated with modifications in chemotherapy... - Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term riskAnil K Chaturvedi
Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
J Natl Cancer Inst 99:1634-43. 2007.... - Second cancers among 40,576 testicular cancer patients: focus on long-term survivorsLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
J Natl Cancer Inst 97:1354-65. 2005..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors... - Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factorsDeirdre A Hill
Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Blood 106:3358-65. 2005..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women... - Risk of second non-hematological malignancies among 376,825 breast cancer survivorsLinda Morris Brown
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Blvd, MSC 7244, Bethesda, MD 20892 7244, USA
Breast Cancer Res Treat 106:439-51. 2007.... - Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 yearsGraca M Dores
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South, Suite 7039, Bethesda, MD 20892, USA
J Clin Oncol 20:3484-94. 2002.... - Suicide after breast cancer: an international population-based study of 723,810 womenCatherine Schairer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Rm 8020, MSC 7244, Rockville, MD 20852 7244, USA
J Natl Cancer Inst 98:1416-9. 2006..08) and remained elevated among women diagnosed between 1990 and 2001 (SMR = 1.36, 95% CI = 1.18 to 1.57). The cumulative probability of suicide was 0.20% 30 years after breast cancer diagnosis... - Second cancers after squamous cell carcinoma and adenocarcinoma of the cervixAnil K Chaturvedi
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
J Clin Oncol 27:967-73. 2009..We assessed whether these cofactor differences translate into differences in second cancer risk... - Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrastLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland 20892, USA
Radiat Res 160:691-706. 2003..Nonetheless, the substantial risks associated with liver cancer and leukemia indicate that unique and prolonged exposure to alpha-particle-emitting Thorotrast increased carcinogenic risks... - Lung cancer following chemotherapy and radiotherapy for Hodgkin's diseaseLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
J Natl Cancer Inst 94:182-92. 2002..We quantified the risk of treatment-associated lung cancer, taking into account tobacco use... - Evaluation of and quality assurance in HER2 analysis in breast carcinomas from patients registered in Danish Breast Cancer Group (DBCG) in the period of 2002-2006. A nationwide study including correlation between HER-2 status and other prognostic variableBirgitte Bruun Rasmussen
Department of Pathology, Nordsjaellands Hospital, Hilleroed, Denmark
Acta Oncol 47:784-8. 2008..The analysis was introduced during the late 1990's, and was gradually intensified in the following years up to now. The present study deals with the experience with the analysis during the last 5 years, from 2002 - 2006... - Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001Michael Andersson
Department of Oncology, Finsen Centre, Rigshospitalet University Hospital, Copenhagen, Denmark
Acta Oncol 47:755-64. 2008..Ovary cancer risk was inversely related to age at diagnosis but not to treatment and corpus uteri cancer risk related to tamoxifen treatment, relative risk 1.57. The findings are in accordance to other population based studies... - Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative GroupMarianne Ewertz
Department of Oncology, Odense University Hospital, University of Southern Denmark, Denmark
Acta Oncol 47:682-90. 2008..This formed the basis for recommending breast conserving surgery combined with radiotherapy as a standard treatment for suited breast cancer patients in Denmark... - Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancerMartine J Piccart-Gebhart
Medicine Department, Jules Bordet Institute, Blvd de Waterloo 125, 1000 Brussels, Belgium
N Engl J Med 353:1659-72. 2005..We investigated its efficacy and safety after excision of early-stage breast cancer and completion of chemotherapy... - Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trialPrudence Francis
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne 8006, Australia
J Natl Cancer Inst 100:121-33. 2008..The Breast International Group 02-98 randomized trial tested the effect of incorporating docetaxel into anthracycline-based adjuvant chemotherapy and compared sequential vs concurrent administration of doxorubicin and docetaxel... - [Trastuzumab improves adjuvant therapy. The Danish Society of Clinical Oncology]Michael Andersson
Onkologisk Klinik 5073, Finsencentret, H:S Rigshospitalet,
Ugeskr Laeger 168:1229. 2006 - [Medical treatment of primary breast cancer: new targeted biological treatments]Michael Andersson
Rigshospitalet, Finsencenter, Onkologisk Klinik, København Ø
Ugeskr Laeger 169:3082-4. 2007..Trastuzumab therapy resulted in relative risk reductions of 33-59% for recurrence and of 33-41% for death. Trastuzumab has become an integral part of adjuvant therapy in HER2-positive operable breast cancer... - Noncancer causes of death in survivors of testicular cancerSophie D Fossa
Department of Clinical Cancer Research, Rikshospitalet Radiumhospitalet Trust, Oslo, Norway
J Natl Cancer Inst 99:533-44. 2007..We conducted a population-based study to quantify the long-term risks of mortality from noncancer causes among men with testicular cancer... - Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphomaDavid C Hodgson
Princess Margaret Hospital, University Health Network, and the Department of Radiation Oncology, University of Toronto, Canada
J Clin Oncol 25:1489-97. 2007..However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis... - [Treatment results in breast cancer: efficiency and costs]Dorte Lisbet Nielsen
Ugeskr Laeger 169:2963. 2007 - [Molecular targeted therapies for metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors]Dorte Lisbet Nielsen
Herlev Hospital, Onkologisk afdeling, Herlev
Ugeskr Laeger 169:3085-7. 2007..The most promising of these new agents are discussed focusing on monoclonal antibodies and tyrosine kinase inhibitors to human epidermal growth factor receptors (HER) and vascular endothelial growth factor (VEGF)...